Evaluation of Hepatoprotective Effect of Silymarin Among Under Treatment Tuberculosis Patients: A Randomized Clinical Trial

Abstract: Hepatic toxicity is the most serious adverse effect of anti-tuberculosis drugs. This study was performed to evaluate the efficacy of silymarin as a hepatoprotective herbal agent. In a randomized double blind clinical trial, 70 new cases of pulmonary tuberculosis were divided into two group...

Descripción completa

Detalles Bibliográficos
Autores principales: Marjani, Majid, Baghaei, Parvaneh, Kazempour Dizaji, Mehdi, Gorji Bayani, Pegah, Fahimi, Fanak, Tabarsi, Payam, Velayati, Ali Akbar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Shaheed Beheshti University of Medical Sciences 2016
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986122/
https://www.ncbi.nlm.nih.gov/pubmed/27610165

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4986122/
https://www.ncbi.nlm.nih.gov/pubmed/27610165

Ejemplares similares